STOCK TITAN

[8-K] Noodles & Company Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

The Form 144 filing shows a Gevo, Inc. (GEVO) shareholder intends to sell up to 28,500 common shares through Stifel Nicolaus on Nasdaq. The block equals roughly 0.01 % of the 239,562,995 shares outstanding and carries an aggregate market value of $35,072, implying a reference price near $1.23 per share. The proposed sale date is 08/05/2025.

The shares were acquired on 08/03/2025 via restricted stock units and will be paid for in cash at settlement. The same seller, Kimberly Bowron, disposed of 35,688 shares during the prior three months for gross proceeds of $45,411. No material adverse information is asserted in the notice, and no additional company financial data are provided.

Il modulo 144 indica che un azionista di Gevo, Inc. (GEVO) intende vendere fino a 28.500 azioni ordinarie tramite Stifel Nicolaus sul Nasdaq. Il blocco rappresenta circa lo 0,01% delle 239.562.995 azioni in circolazione e ha un valore di mercato complessivo di 35.072 dollari, corrispondente a un prezzo di riferimento di circa 1,23 dollari per azione. La data prevista per la vendita è il 05/08/2025.

Le azioni sono state acquisite il 03/08/2025 tramite unità azionarie vincolate e saranno pagate in contanti al momento del regolamento. La stessa venditrice, Kimberly Bowron, ha ceduto 35.688 azioni nei tre mesi precedenti, ottenendo un ricavo lordo di 45.411 dollari. Nel comunicato non sono presenti informazioni negative rilevanti e non sono forniti ulteriori dati finanziari dell’azienda.

El formulario 144 muestra que un accionista de Gevo, Inc. (GEVO) tiene la intención de vender hasta 28,500 acciones comunes a través de Stifel Nicolaus en Nasdaq. El bloque equivale aproximadamente al 0,01 % de las 239,562,995 acciones en circulación y tiene un valor de mercado agregado de $35,072, lo que implica un precio de referencia cercano a $1.23 por acción. La fecha propuesta para la venta es el 05/08/2025.

Las acciones fueron adquiridas el 03/08/2025 mediante unidades restringidas de acciones y se pagarán en efectivo al momento del liquidación. La misma vendedora, Kimberly Bowron, vendió 35,688 acciones durante los tres meses anteriores, obteniendo ingresos brutos de $45,411. No se afirma información adversa material en el aviso y no se proporcionan datos financieros adicionales de la empresa.

Form 144 제출서에 따르면 Gevo, Inc. (GEVO)의 주주가 Stifel Nicolaus를 통해 나스닥에서 최대 28,500 보통주를 매도할 의사를 나타냈습니다. 해당 블록은 전체 239,562,995 주의 약 0.01%에 해당하며, 총 시장 가치는 35,072 달러로 주당 약 1.23달러의 기준 가격을 시사합니다. 예정된 매도일은 2025년 8월 5일입니다.

이 주식들은 2025년 8월 3일 제한 주식 단위를 통해 취득되었으며, 결제 시 현금으로 지급될 예정입니다. 동일한 판매자 Kimberly Bowron는 이전 3개월 동안 35,688 주를 처분하여 총 45,411달러의 수익을 올렸습니다. 공지에는 중대한 부정적 정보가 없으며, 추가 회사 재무 데이터도 제공되지 않았습니다.

Le dépôt du formulaire 144 indique qu’un actionnaire de Gevo, Inc. (GEVO) a l’intention de vendre jusqu’à 28 500 actions ordinaires via Stifel Nicolaus sur le Nasdaq. Le bloc représente environ 0,01 % des 239 562 995 actions en circulation et a une valeur marchande totale de 35 072 $, ce qui implique un prix de référence proche de 1,23 $ par action. La date de vente proposée est le 05/08/2025.

Les actions ont été acquises le 03/08/2025 par le biais d’unités d’actions restreintes et seront réglées en espèces. La même vendeuse, Kimberly Bowron, a cédé 35 688 actions au cours des trois mois précédents, pour un produit brut de 45 411 $. Aucune information défavorable importante n’est mentionnée dans l’avis, et aucune donnée financière supplémentaire de la société n’est fournie.

Die Form 144 zeigt, dass ein Aktionär von Gevo, Inc. (GEVO) beabsichtigt, bis zu 28.500 Stammaktien über Stifel Nicolaus an der Nasdaq zu verkaufen. Das Paket entspricht etwa 0,01 % der 239.562.995 ausstehenden Aktien und hat einen Gesamtmarktwert von 35.072 US-Dollar, was auf einen Referenzpreis von etwa 1,23 US-Dollar pro Aktie hindeutet. Das geplante Verkaufsdatum ist der 05.08.2025.

Die Aktien wurden am 03.08.2025 durch eingeschränkte Aktieneinheiten erworben und werden bei Abwicklung in bar bezahlt. Derselbe Verkäufer, Kimberly Bowron, veräußerte in den vorangegangenen drei Monaten 35.688 Aktien mit Bruttoerlösen von 45.411 US-Dollar. Im Hinweis werden keine wesentlichen negativen Informationen angegeben, und es werden keine zusätzlichen Finanzdaten des Unternehmens bereitgestellt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small Form 144 sale (~0.01 % float) appears routine and is unlikely to materially impact GEVO’s valuation.

The filing registers 28,500 shares, valued at just $35k, for potential sale. With over 239 million shares outstanding, the transaction is de-minimis. The seller has gradually reduced her position—totaling 64,188 shares in three months—yet even combined proceeds remain immaterial relative to Gevo’s market cap. Absence of adverse disclosures or unusual payment terms suggests a standard liquidity event rather than a signal about fundamentals. I classify the impact on investors as neutral.

Il modulo 144 indica che un azionista di Gevo, Inc. (GEVO) intende vendere fino a 28.500 azioni ordinarie tramite Stifel Nicolaus sul Nasdaq. Il blocco rappresenta circa lo 0,01% delle 239.562.995 azioni in circolazione e ha un valore di mercato complessivo di 35.072 dollari, corrispondente a un prezzo di riferimento di circa 1,23 dollari per azione. La data prevista per la vendita è il 05/08/2025.

Le azioni sono state acquisite il 03/08/2025 tramite unità azionarie vincolate e saranno pagate in contanti al momento del regolamento. La stessa venditrice, Kimberly Bowron, ha ceduto 35.688 azioni nei tre mesi precedenti, ottenendo un ricavo lordo di 45.411 dollari. Nel comunicato non sono presenti informazioni negative rilevanti e non sono forniti ulteriori dati finanziari dell’azienda.

El formulario 144 muestra que un accionista de Gevo, Inc. (GEVO) tiene la intención de vender hasta 28,500 acciones comunes a través de Stifel Nicolaus en Nasdaq. El bloque equivale aproximadamente al 0,01 % de las 239,562,995 acciones en circulación y tiene un valor de mercado agregado de $35,072, lo que implica un precio de referencia cercano a $1.23 por acción. La fecha propuesta para la venta es el 05/08/2025.

Las acciones fueron adquiridas el 03/08/2025 mediante unidades restringidas de acciones y se pagarán en efectivo al momento del liquidación. La misma vendedora, Kimberly Bowron, vendió 35,688 acciones durante los tres meses anteriores, obteniendo ingresos brutos de $45,411. No se afirma información adversa material en el aviso y no se proporcionan datos financieros adicionales de la empresa.

Form 144 제출서에 따르면 Gevo, Inc. (GEVO)의 주주가 Stifel Nicolaus를 통해 나스닥에서 최대 28,500 보통주를 매도할 의사를 나타냈습니다. 해당 블록은 전체 239,562,995 주의 약 0.01%에 해당하며, 총 시장 가치는 35,072 달러로 주당 약 1.23달러의 기준 가격을 시사합니다. 예정된 매도일은 2025년 8월 5일입니다.

이 주식들은 2025년 8월 3일 제한 주식 단위를 통해 취득되었으며, 결제 시 현금으로 지급될 예정입니다. 동일한 판매자 Kimberly Bowron는 이전 3개월 동안 35,688 주를 처분하여 총 45,411달러의 수익을 올렸습니다. 공지에는 중대한 부정적 정보가 없으며, 추가 회사 재무 데이터도 제공되지 않았습니다.

Le dépôt du formulaire 144 indique qu’un actionnaire de Gevo, Inc. (GEVO) a l’intention de vendre jusqu’à 28 500 actions ordinaires via Stifel Nicolaus sur le Nasdaq. Le bloc représente environ 0,01 % des 239 562 995 actions en circulation et a une valeur marchande totale de 35 072 $, ce qui implique un prix de référence proche de 1,23 $ par action. La date de vente proposée est le 05/08/2025.

Les actions ont été acquises le 03/08/2025 par le biais d’unités d’actions restreintes et seront réglées en espèces. La même vendeuse, Kimberly Bowron, a cédé 35 688 actions au cours des trois mois précédents, pour un produit brut de 45 411 $. Aucune information défavorable importante n’est mentionnée dans l’avis, et aucune donnée financière supplémentaire de la société n’est fournie.

Die Form 144 zeigt, dass ein Aktionär von Gevo, Inc. (GEVO) beabsichtigt, bis zu 28.500 Stammaktien über Stifel Nicolaus an der Nasdaq zu verkaufen. Das Paket entspricht etwa 0,01 % der 239.562.995 ausstehenden Aktien und hat einen Gesamtmarktwert von 35.072 US-Dollar, was auf einen Referenzpreis von etwa 1,23 US-Dollar pro Aktie hindeutet. Das geplante Verkaufsdatum ist der 05.08.2025.

Die Aktien wurden am 03.08.2025 durch eingeschränkte Aktieneinheiten erworben und werden bei Abwicklung in bar bezahlt. Derselbe Verkäufer, Kimberly Bowron, veräußerte in den vorangegangenen drei Monaten 35.688 Aktien mit Bruttoerlösen von 45.411 US-Dollar. Im Hinweis werden keine wesentlichen negativen Informationen angegeben, und es werden keine zusätzlichen Finanzdaten des Unternehmens bereitgestellt.

0001275158false00012751582025-08-052025-08-05

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_______________
 
FORM 8-K
 
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported): August 5, 2025
 
NOODLES & COMPANY
(Exact name of registrant as specified in its charter)
 
Delaware001-3598784-1303469
(State or Other Jurisdiction of(Commission File Number)(I.R.S. Employer
Incorporation)Identification No.)
520 Zang Street, Suite D 
Broomfield, CO80021
(Address of principal executive offices)(Zip Code)
 
Registrant’s Telephone Number, Including Area Code: (720) 214-1900
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A common stockNDLSNasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



 
Item 5.02. Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 5, 2025, Noodles & Company (the “Company”) announced that the Company’s current President and Chief Operating Officer, Joseph Christina, has been appointed President and Chief Executive Officer by the Company’s Board of Directors (the “Board”), and elected to serve as a member of the Board, effective August 31, 2025 (the “Effective Date”). Mr. Christina will succeed the Company’s current Chief Executive Officer, Drew Madsen, as of the Effective Date. Mr. Madsen is stepping down as Chief Executive Officer for personal medical reasons, but will facilitate the transition through August and continue to serve as a member of the Board.

Mr. Christina has served as the Company’s President and Chief Operating Officer since February 2025. Prior to joining the Company, he was Chief Executive Officer of Tijuana Flats, a restaurant chain serving Tex-Mex cuisine, from 2022 to July 2024. Prior to this, he served as EVP, US Operations and then CEO, President, and Board Member of Church’s Chicken, a fast food restaurant chain that specializes in fried chicken, positions he held from 2013 to August of 2022. Mr. Christina’s career began at Burger King, where he worked for 29 years, climbing through key positions such as Restaurant Manager, Franchise Owner, VP of Global Operations and Training, and ultimately SVP of Franchise Operations for the West Division. He holds a Bachelor of Science in Business Management and Marketing from Quinnipiac University and brings to the Company’s Board of Directors his perspective on the Company’s operations as an executive officer and broad experience in restaurant operations and restaurant brand development.

In connection with Mr. Christina’s appointment as President and Chief Executive Officer, the Company and Mr. Christina entered into an amended and restated employment agreement, dated August 5, 2025 (the “Employment Agreement”) and, in connection with his appointment to the Board, the parties entered into the Company’s standard form of indemnification agreement for directors. The Employment Agreement provides that, as of the Effective Date, Mr. Christina will receive an annual base salary of $550,000 and an annual bonus opportunity for the fiscal year in an amount targeted at 100% of his base salary (pro-rated for February 2025 hire date), subject to the achievement of performance conditions established by the Board or the Compensation Committee in their discretion. In addition, Mr. Christina will receive an initial equity grant of 250,000 restricted stock units under the Company's Amended and Restated 2023 Stock Incentive Plan (the “Plan”) on the Effective Date, which will vest in four annual ratable installments subject to the terms of a separate grant agreement. Mr. Christina will continue to be entitled to the standard benefits available to the Company’s executives generally, including health insurance, life and disability coverage and the option to participate in the Company’s 401(k) Savings Plan.

The Employment Agreement maintains Mr. Christina’s existing rights upon certain termination events that were set forth in his February agreement, except that if Mr. Christina’s employment is terminated by the Company without cause, or he voluntarily terminates his employment for good reason, Mr. Christina will be entitled to receive 12 months of his base salary and COBRA premium rather than 9 months.

The Employment Agreement also prohibits Mr. Christina from competing with the Company and soliciting employees of the Company for 12 months following his termination of employment for any reason. Mr. Christina is also subject to confidentiality, cooperation, return of business records and equipment, and non-disparagement covenants.

On August 5, 2025, the Company entered into a transition agreement with Mr. Madsen (the “Transition Agreement”). The Transition Agreement sets forth Mr. Madsen’s resignation as of August 31, 2025 and provides for mutual releases and that the equity awards granted under the Plan then held by Mr. Madsen will be treated as follows: (a) the unvested portion of the grant of 199,203 restricted stock units (“RSUs”) will continue to vest in accordance with the existing terms of the award so long as Mr. Madsen continues to serve as a member of the Board and (b) all other outstanding equity awards that are not then vested will be canceled. Mr. Madsen will be entitled to receive compensation in the form and amount set forth in the Amended and Restated Compensation Plan for Non-Employee Directors (the “Director Plan”) beginning as of the Effective Date during his service as a non-employee director, with his first equity award under the Director Plan to be the annual grant in 2026.

Mr. Madsen continues to be bound by the confidentiality and restrictive covenant provisions set forth in the employment agreement, dated March 6, 2024, between the Company and Mr. Madsen and remains a party to an indemnification agreement with the Company.

The preceding summaries of each of the Employment Agreement and the Transition Agreement are qualified in their entirety by reference to the complete terms and conditions of each of the Employment Agreement and the Transition Agreement, which will be filed as exhibits to the Company’s next Form 10-Q.





Item 7.01. Regulation FD Disclosure.

On August 5, 2025, the Company issued a press release announcing the appointment of Mr. Christina as President and Chief Executive Officer to succeed Mr. Madsen and as a director.

The press release also announced the Company’s decision to reschedule the conference call and press release discussing its second quarter 2025 financial results that were to occur after the close of market on Wednesday, August 6, 2025. The conference call will now be held on Wednesday, August 13, 2025 at 4:30 p.m. ET and the press release will be issued after the market close that same day.

A copy of the Company’s press release is included as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.
Exhibit No.
Description
99.1
Noodles & Company Press Release dated August 5, 2025
104
Cover Page Interactive Data File. The cover page XBRL tags are embedded within the Inline XBRL document.







 






SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
Noodles & Company
 DATE: August 5, 2025By:/s/ Mike Hynes
Name:Mike Hynes
Title:Chief Financial Officer


Noodles & Co

NASDAQ:NDLS

NDLS Rankings

NDLS Latest News

NDLS Latest SEC Filings

NDLS Stock Data

38.59M
32.64M
6.13%
59.04%
1.44%
Restaurants
Retail-eating Places
Link
United States
BROOMFIELD